JP Morgan Maintains Overweight on Nuvalent, Raises Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anupam Rama has maintained an Overweight rating on Nuvalent (NASDAQ:NUVL) and increased the price target from $100 to $125.
October 04, 2024 | 6:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan has reaffirmed its Overweight rating on Nuvalent and increased the price target from $100 to $125, indicating a positive outlook on the stock.
The increase in price target from $100 to $125 by JP Morgan suggests a strong positive sentiment towards Nuvalent's future performance. The Overweight rating indicates that the analyst expects the stock to outperform its peers, which is likely to boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100